Often referred to as a "rebound" or "relapse" of COVID-19 after taking the standard five days ofPaxlovid pills, experts say key questions need to be answered around why it happens, who is being affected, and how doctors should handle the cases. ...
President Joe Biden tested positive for SARS-CoV-2 again on Monday, the White House announced — the third day in a row he tested positive after testing negative for 3 days last week.Caitlyn StulpinInfectious Disease News
The Administration for Strategic Preparedness and Response is also working on a way the website might be incorporated into the Biden administration's"test-to-treat"initiative, connecting people who test positive with COVID treatments like Pfizer's Paxlovid. "What if you could do a test at home...
Hochul's office notes new vaccines, developed to target Omicron variants should be released by the three major COVID-19 vaccine producers in September. "The Department of Health remains vigilant for changes to the virus that could further threaten our public health. We continue to monitor as new...
A large number of medicines are metabolized by CYP3A, and therefore, that the inclusion of ritonavir in the drug combination is likely to create complexities and restrictions in its use.2 Future widespread community use of oral nirmatrelvir/ritonavir (Paxlovid) has implications for those ...
If you notice a nasty taste in your mouth after taking the antiviral pill Paxlovid for COVID-19, you're not imagining it.
When it comes to COVID, people living in disadvantaged communities are hit with a triple whammy. First, they're more likely to get infected, and when sick, are more likely to have serious disease. Second, they're more likely to develop long COVID. Third,
The other newly approved agent is a combination of two drugs—nirmatrelvir and ritonavir—called Paxlovid. Nirmatrelvir blocks the action of an enzyme the virus uses to replicatewhileritonavir (which is also used in an HIV drug) boosts the levels of nirmatrelvir to maintain its effectiveness....